Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

MEMSEL, INC.

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 17, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
ed6bd248-d911-4e29-9bd7-13256821e1b1
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Literal federal measure citations: H.R.8774, S.4921, H.R.4016, S.2572

DEF · Defense

Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Literal federal measure citations: H.R.8774, S.4921, H.R.4016, S.2572

HCR · Health Issues

Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016/S.2572, Department of Defense Appropriations Act, FY2026

Literal federal measure citations: H.R.8774, S.4921, H.R.4016, S.2572

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.